Carisma Therapeutics Inc (CARM)

Jan 06, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Receives Average Rating of “Hold” from Analysts - Defense World

Jan 06, 2025

Jan 03, 2025

Barclays PLC Grows Holdings in Carisma Therapeutics, Inc. (NASDAQ:CARM) - Defense World

Jan 03, 2025

Jan 03, 2025

Layoff Tracker: Regeneron Acquisition of Oxular Wipes Out Oxular Workforce - BioSpace

Jan 03, 2025

Dec 30, 2024

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in September 2023 - GuruFocus.com

Dec 30, 2024

Dec 27, 2024

4BIO Capital Portfolio Company Carisma to Collaborate with Moderna to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology - Quantisnow

Dec 27, 2024

Dec 26, 2024

Carisma Therapeutics Appoints Interim VP of Finance - TipRanks

Dec 26, 2024

Dec 20, 2024

Carisma Therapeutics Refocuses Strategy, Reduces Workforce Amid Pipeline Reprioritization - MSN

Dec 20, 2024

Dec 18, 2024

Carisma downgraded by H.C. Wainwright to neutral - MSN

Dec 18, 2024

Dec 17, 2024

Carisma Therapeutics (NASDAQ:CARM) Given Neutral Rating at HC Wainwright - Defense World

Dec 17, 2024

Dec 16, 2024

HC Wainwright & Co. Downgrades Carisma Therapeutics (CARM) - MSN

Dec 16, 2024

Dec 15, 2024

Carisma Therapeutics (NASDAQ:CARM) Cut to Neutral at Robert W. Baird - Defense World

Dec 15, 2024

Dec 13, 2024

Carisma downgraded by Baird over lack of near-term catalysts - MSN

Dec 13, 2024

Dec 13, 2024

Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference - Kilgore News Herald

Dec 13, 2024

Dec 12, 2024

Baird Downgrades Carisma Therapeutics (CARM) - MSN

Dec 12, 2024

Dec 12, 2024

BTIG cuts Carisma Therapeutics to Neutral from Buy By Investing.com - Investing.com Nigeria

Dec 12, 2024

Dec 12, 2024

Carisma downgraded by Baird over lack of near-term catalysts (CARM:NASDAQ) - Seeking Alpha

Dec 12, 2024

Dec 12, 2024

Carisma Therapeutics downgraded to Neutral from Outperform at Baird - MSN

Dec 12, 2024

Dec 12, 2024

BTIG Downgrades Carisma Therapeutics (CARM) - MSN

Dec 12, 2024

Dec 12, 2024

Evercore ISI Group Downgrades Carisma Therapeutics (CARM) - MSN

Dec 12, 2024

Dec 11, 2024

Carisma Therapeutics Announces Upcoming Presentations at SITC 2024 - The Eastern Progress Online

Dec 11, 2024

Dec 11, 2024

Carisma Therapeutics cut to In Line, stock target slashed on tempered outlook - Investing.com

Dec 11, 2024

Dec 10, 2024

Carisma Therapeutics Drops GC As Part Of Cutbacks - Law360

Dec 10, 2024

Dec 10, 2024

Carisma Therapeutics Announces Strategic Restructuring to Re-Prioritize Pipeline and A Reduction in the Workforce by 34% - Marketscreener.com

Dec 10, 2024

Dec 10, 2024

Carisma Therapeutics shifts focus, cuts workforce by 34% - Investing.com Nigeria

Dec 10, 2024

Dec 09, 2024

BTIG cuts Carisma Therapeutics to Neutral from Buy - Investing.com

Dec 09, 2024

Dec 09, 2024

Penn spinout Carisma Therapeutics to narrow R&D focus, lay off more than a third of its workforce - The Business Journals

Dec 09, 2024

Dec 09, 2024

Carisma Therapeutics shifts focus, cuts workforce by 34% By Investing.com - Investing.com South Africa

Dec 09, 2024

Dec 09, 2024

Carisma Therapeutics Reprioritizes Pipeline, Cuts Jobs - Contract Pharma

Dec 09, 2024

Dec 09, 2024

Carisma Therapeutics Announces Strategic Restructuring to Re-pri - GuruFocus.com

Dec 09, 2024

Dec 09, 2024

Carisma Therapeutics Restructures Amid Strategic Refocus - TipRanks

Dec 09, 2024

Dec 09, 2024

Carisma Therapeutics Pivots Strategy, Cuts 34% of Workforce to Focus on Macrophage Platform - StockTitan

Dec 09, 2024

Dec 08, 2024

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma - The Eastern Progress Online

Dec 08, 2024

Dec 07, 2024

Carisma Therapeutics to Present at Upcoming Conferences - The Eastern Progress Online

Dec 07, 2024

Dec 06, 2024

Carisma Therapeutics Announces Changes to its Board of Directors - The Eastern Progress Online

Dec 06, 2024

Dec 06, 2024

Investors Don't See Light At End Of Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Tunnel And Push Stock Down 28% - Simply Wall St

Dec 06, 2024

Dec 05, 2024

CARM Stock Hits 52-Week Low at $0.8 Amid Market Challenges - Investing.com

Dec 05, 2024

Dec 03, 2024

Carisma Therapeutics CEO to Speak at 7th Annual Evercore ISI HealthCONx Conference - MSN

Dec 03, 2024

Nov 29, 2024

Carisma Therapeutics Announces Upcoming Presentations at SITC 20 - GuruFocus.com

Nov 29, 2024

Nov 25, 2024

Carisma Therapeutics stock target cut, maintains buy on clinical trial - Investing.com

Nov 25, 2024

Nov 25, 2024

Carisma Therapeutics stock target cut, maintains buy on clinical trial By Investing.com - Investing.com Canada

Nov 25, 2024

Nov 25, 2024

Carisma Therapeutics price target lowered to $5 from $8 at H.C. Wainwright - TipRanks

Nov 25, 2024

Nov 22, 2024

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CA - GuruFocus.com

Nov 22, 2024

Nov 22, 2024

Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GuruFocus.com

Nov 22, 2024

Nov 20, 2024

Carisma Therapeutics Reports Q3 2024 Results, Advances Clinical Programs - MSN

Nov 20, 2024

Nov 17, 2024

Carisma Therapeutics and Moderna Unveil Promising Pre-Clinical Data for Anti-GPC3 CAR-M Therapy - MSN

Nov 17, 2024

Nov 17, 2024

Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024 - PR Newswire

Nov 17, 2024